Rosuvastatin calcium10mg

DRUG3 trials

Sponsors

Seung-Jung Park, Kobe University, Kaken Pharmaceutical

Conditions

Angina PectorisCoronary Artery DiseaseHealty Volunteers

Phase 1

To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers

CompletedNCT06821698

Kaken PharmaceuticalHealty Volunteers

Start: 2025-02-13End: 2025-05-20Updated: 2025-09-12

Phase 4

Statin and Atheroma Vulnerability Evaluation

CompletedNCT00997880

Seung-Jung ParkCoronary Artery Disease

Start: 2010-04-30End: 2014-12-31Updated: 2014-12-25

Effect of Alirocumab(Proprotein Convertase Subtilisin/Kexin type9 Inhibitor) and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaques in Coronary Artery Disease Evaluated by Near-infrared Spectroscopy Intravascular Ultrasound

Kobe UniversityAngina Pectoris, Coronary Artery Disease

Start: 2018-04-01End: 2020-09-30Target: 30Updated: 2018-08-31

Related Papers

Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy

Circulation Cardiovascular Imaging2017-07-0137 citations

Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.

2016-04-0170 citations